Outcomes Following Bronchial Artery Embolisation for Haemoptysis in Cystic Fibrosis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background Bronchial artery embolisation (BAE) is recommended for the treatment of massive haemoptysis in cystic fibrosis (CF), but there are no randomised controlled trials of this therapy and its role in sub-massive haemoptysis is unclear. This study aimed to determine the outcomes and safety of BAE in adults with CF.Materials and methods All patients with CF undergoing BAE at our centre between March 2011 and January 2015 were identified at the time of the procedure. Patient records were reviewed at hospital discharge, death or one month post-procedure (whichever was soonest). Follow-up continued to January 2016. Severity of haemoptysis was classified as: massive (>240 ml/24 h or >100 ml/day for ≥2 days), moderate-severe (>20 ml/24 h) or mild (<20 ml/24 h).Results Twenty-seven patients underwent 51 BAE procedures over a median follow-up period of 26 months (range 1-54). Ten patients (37%) required more than one BAE during the study. BAE was performed for massive haemoptysis in 18 cases (35%). Haemoptysis recurred after 31 (61%) of BAE procedures with no difference in recurrence rates between massive and sub-massive haemoptysis. Side effects were reported after 61% of procedures with chest pain the most common adverse event . Mortality after first BAE in the study was 3.9% at 30 days and 14.8% at 12 months. No significant predictors of mortality were identified.Conclusions BAE is often effective in controlling haemoptysis but is associated with considerable morbidity and high recurrence rates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Independent of FEV1, the following factors have been associated with increasing risk of disease progression or death: frequent or severe exacerbations, massive hemoptysis requiring bronchial artery embolization, pneumothorax, malnutrition, low six-minute walk distance, and younger age upon development of advanced disease.(247, 252–260)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [255]
Citations
Cites
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement
Sukeik, M., Alshryda, S., Haddad, F. S., & Mason, J. M. (2011) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.93b1.24984 · Cited by 428
Clinical assessment and management of massive hemoptysis
Jean-Baptiste, E. (2000) · Critical Care Medicine · doi:10.1097/00003246-200005000-00066 · Cited by 427
Immediate and Long-term Results of Bronchial Artery Embolization for Life-Threatening Hemoptysis
Mal, H., Rullon, I., Mellot, F., Brugière, O., Sleiman, C., Menu, Y., & Fournier, M. (1999) · Chest · doi:10.1378/chest.115.4.996 · Cited by 338
Antifibrinolytic drugs for acute traumatic injury
Ker, K., Roberts, I., Shakur, H., & Coats, T. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004896.pub4 · Cited by 320
Bonnar, J., & Sheppard, B. L. (1996) · BMJ · doi:10.1136/bmj.313.7057.579 · Cited by 275
Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Rosenblatt, R. L., Quittell, L. M., & Marshall, B. C. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0157ci · Cited by 269
Massive hemoptysis in cystic fibrosis
Flume, P. A., Yankaskas, J. R., Ebeling, M., Hulsey, T., & Clark, L. L. (2005) · Chest · doi:10.1378/chest.128.2.729 · Cited by 215
Massive hemoptysis. Review of 123 cases.
Conlan, A. A., Ss, H., Lp, K., Nicolaou, N., & Pool, R. (1983) · PubMed · Cited by 172
Bronchial Artery Embolization for the Treatment of Hemoptysis in Patients with Cystic Fibrosis
Brinson, G. M., Noone, P. G., Mauro, M. A., Knowles, M. R., Yankaskas, J. R., Sandhu, J. S., & Jaques, P. F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9708067 · Cited by 154
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
CIRSE Standards of Practice on Bronchial Artery Embolisation
Kettenbach, J., Ittrich, H., Gaubert, J. Y., Gebauer, B., & Vos, J. A. (2022) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-022-03127-w · Cited by 93
Management of life-threatening hemoptysis in the ICU
Charya, A. V., Holden, V. K., & Pickering, E. M. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-19-3991 · Cited by 50
Lehr, C. J., Skeans, M., Dasenbrook, E., Fink, A., Fernandez, G., Faro, A., & Valapour, M. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0252oc · Cited by 35
“Massive hemoptysis is also known to be associated with significant morbidity and mortality for patients with CF with end-stage lung disease and has not historically been included in transplant registries (19, 20).”
BackgroundPulmonary Complications in Cystic Fibrosis: Past, Present, and Future
Mingora, C. M., & Flume, P. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.017 · Cited by 32
Metadata
- Authors
- Flight, W. G., Barry, P. J., Bright-Thomas, R. J., Butterfield, S., Ashleigh, R., & Jones, A. M.
- Affiliations
- Oxford University Hospitals NHS Trust (GB)
- University of Manchester (GB)
- Corresponding author
- Flight, W. G.
- Venue
- CardioVascular and Interventional Radiology
- Published
- 2017-03-13
- Volume
- 40
- Issue
- 8
- Pages
- 1164-1168
- ISSN
- 0174-1551 (ISSN-L)
- 1432-086X
- OpenAlex
- W2596555727
- Cited by
- 28
- References
- 23
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 2 · 2019: 6
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CardioVascular and Interventional Radiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Tracheal and airway disorders
- Keywords
- bronchial artery embolization, hemoptysis, cystic fibrosis, procedural safety, post-procedural mortality, chest pain
- MeSH terms
- Adolescent, Adult, Aged, Bronchial Arteries, Cystic Fibrosis, Embolization, Therapeutic, Female, Follow-Up Studies, Hemoptysis, Humans, Male, Middle Aged, Prospective Studies, Recurrence, Severity of Illness Index, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcomes Following Bronchial Artery Embolisation for Haemoptysis in Cystic Fibrosis. https://app.cochat.ai/papers/10.1007/s00270-017-1626-0
- The paper
- Flight, W. G., Barry, P. J., Bright-Thomas, R. J., Butterfield, S., Ashleigh, R., & Jones, A. M. (2017). Outcomes Following Bronchial Artery Embolisation for Haemoptysis in Cystic Fibrosis. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-017-1626-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.